Incidence and Management of Carfilzomib-induced Cardiovascular Toxicity; A Systematic Review and Meta-analysis.
Latif A, Kapoor V, Lateef N, Ahsan MJ, Usman RM, Malik SU, Ahmad N, Rosko N, Rudoni J, William P, Khouri J, Anwer F.
Latif A, et al. Among authors: kapoor v.
Cardiovasc Hematol Disord Drug Targets. 2021;21(1):30-45. doi: 10.2174/1871529X21666210412113017.
Cardiovasc Hematol Disord Drug Targets. 2021.
PMID: 33845729